saRNA Molecules Modulate HNF4a Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for targeted modulation of HNF4a gene expression for therapeutic purposes, particularly in treating metabolic disorders and hyperproliferative diseases, as existing methods lack effective solutions for regulating HNF4a pathways.
Innovation Solution
Development of short activating RNA (saRNA) molecules that specifically target and modulate HNF4a gene expression, including designing and using pharmaceutical compositions comprising saRNA to upregulate or downregulate HNF4a gene function for therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing methods are used for gene regulation, then general gene modulation is achieved, but targeted modulation of HNF4a pathways is not effective
Solution Approach 1:
The patent uses short activating RNA (saRNA) molecules as intermediary agents to specifically target and modulate HNF4a gene expression. The saRNA acts as a mediator between the therapeutic goal and the target gene, enabling precise control of HNF4a pathways while avoiding off-target effects of conventional methods
Solution Approach 2:
The invention changes the molecular parameters by introducing chemically modified nucleotide sequences in the saRNA structure. These parameter changes in RNA composition and structure enable specific binding to HNF4a mRNA, achieving targeted modulation with high precision and therapeutic reliability
2Ease of operation
If HNF4a gene expression is modulated using conventional approaches, then general transcriptional regulation occurs, but specific upregulation or downregulation of HNF4a pathways is not achieved
Solution Approach 1:
The patent segments the therapeutic approach by designing saRNA molecules that specifically target different regions of HNF4a mRNA. This segmentation enables independent control of HNF4a upregulation or downregulation, improving both the ease of operation and therapeutic efficiency for different disease conditions
Solution Approach 2:
The saRNA platform demonstrates multi-functionality by being able to both upregulate and downregulate HNF4a gene expression depending on the specific sequence design. This universal capability allows the same therapeutic platform to address diverse metabolic disorders and hyperproliferative diseases effectively
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The saRNA molecules effectively modulate HNF4a gene expression, demonstrating upregulation of HNF4a protein levels and associated biological effects, such as regulating lipid metabolism and glucose metabolism, providing potential therapeutic benefits for metabolic disorders and hyperproliferative diseases.
Implementation Method 1
The saRNA molecules effectively modulate HNF4a gene expression, demonstrating upregulation of HNF4a protein levels
Data Source
AI summary
The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.